Bridgeway Capital Management’s CareDx CDNA Stock Holding History

Bridgeway Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-71,598	Closed	-$2.07M	–	1381
2018 Q3	$2.07M	Sell	71,598 -65,000	-48%	-$1.22M	0.02%	625
2018 Q2	$1.67M	Hold	136,598	–	–	0.02%	692
2018 Q1	$1.09M	Buy	136,598 +25,000	+22%	+$154K	0.01%	818
2017 Q4	$819K	Sell	111,598 -58,400	-34%	-$364K	0.01%	920
2017 Q3	$629K	Hold	169,998	–	–	0.01%	1020
2017 Q2	$189K	Sell	169,998 -30,000	-15%	-$31.9K	﹤0.01%	1302
2017 Q1	$280K	Buy	199,998 +100,000	+100%	+$223K	﹤0.01%	1222
2016 Q4	$270K	Sell	99,998 -42,534	-30%	-$147K	﹤0.01%	1250
2016 Q3	$506K	Buy	142,532 +51,782	+57%	+$238K	0.01%	1099
2016 Q2	$392K	Hold	90,750	–	–	0.01%	1147
2016 Q1	$450K	Hold	90,750	–	–	0.01%	1099
2015 Q4	$581K	Buy	90,750 +80,750	+808%	+$440K	0.01%	996
2015 Q3	$42K	Hold	10,000	–	–	﹤0.01%	1442
2015 Q2	$65K	Buy	+10,000	New	+$54.3K	﹤0.01%	1453

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bridgeway Capital Management's CDNA Position: Q4 2018 in Review

Bridgeway Capital Management sold out of CareDx (CDNA) in Q4 2018, closing a stake of 71,598 shares — an estimated $2.07M sold.

Bridgeway Capital Management first reported a position in CDNA in Q2 2015 and held it in 14 quarters. The position peaked at $2.07M in Q3 2018. 148 funds tracked by Wall St. Rank hold CDNA as of Q4 2018.

Bridgeway Capital Management reported no remaining CareDx position as of Q4 2018 after selling out during the quarter.
Bridgeway Capital Management sold 71,598 CareDx shares in Q4 2018, an estimated $2.07M.
Bridgeway Capital Management first reported a position in CareDx in Q2 2015 and held it in 14 quarters.
Bridgeway Capital Management's CareDx position peaked at $2.07M in Q3 2018.
148 funds tracked by Wall St. Rank held CareDx as of Q4 2018.

Based on Bridgeway Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.